ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Technology / HNGE / forecast
QNT (53) AUR (37) JKHY (82) EPAM (83) ⌘ Pro Terminal →

Hinge Health Inc. (HNGE) 12-Month Stock Forecast & Price Target Cone

$115.48 +1.01% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $115.47

Hinge Health Inc. (HNGE) carries a Roarable Rating of C+ (Hold) with 68/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $9.22B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HNGE Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is HNGE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Hinge Health Inc. (NYSE: HNGE) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $115.48 (+1.01% 1D, market cap $9.22B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 19/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 10/20. Across 715 tracked Technology issuers, HNGE ranks #105 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does HNGE compare to QNT and AUR in the Technology sector?
▼

Within the Technology sector (EDP Services), HNGE carries a Roarable C+ (68/100 RQD), trailing P/E of N/A, gross margin of 79.6%, and ROIC of -35.0%. By comparison, QNT (Quantinuum Inc.) holds a D+ grade (53/100 RQD, P/E 21.7x, ROIC 58.3%, cap $8.93B) and AUR (Aurora Innovation Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $8.81B). Among the 5-stock peer group, EPAM leads on earnings multiple (18.4x) while QNT leads on capital efficiency (58.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HNGE?
▼

Per HNGE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001673743), Hinge Health Inc. generated $587.9M in revenue (+50.6% YoY), -$528.3M in net income, and $170.7M in free cash flow against $744.8M in total assets and $164.8M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $115.47 (-0.01%)🧬 Disciplined Float (+0.52% YoY Shares)⚙️ Cash Engine: 13/20 (C) • 29% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 68/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.8% avg 90D alpha vs SPY • 56.9% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C+
025507510068
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B- · Rk C
Cash (13)Whales (19)SEC (16)Macro (10)CEO (10)
Each axis scored 0–20
12M PRICE TARGET CONE+4.5% Base Target
$142 Bull$121 Base$94 Bear
📬 FREE HNGE RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HNGE)Realized 20D OHLCV Swing Band: ±8.2%
Deterministic 5-Pillar Attribution (68/100 Composite)
🔍 WHY HNGE SCORES 68/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+19/20 pts (28% of score)

20D Institutional Volume Accumulation (±8.2% realized swing band)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (24% of score)

Altman Z-Score 12.12 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution10/20 pts (-10 pt drag)

Disciplined Float (+0.52% YoY Shares) & executive Form 4 sales trim 10 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
60
Grade C$105.00+6.7% Next Q
Q2 (-2Q)
63
Grade C+$112.00+2.9% Next Q
Q3 (-1Q)
65
Grade C+$115.28+0.2% Next Q
Current
68
Grade C+$115.48+1.8% Hist 90D α
Trajectory: C (60) → C+ (68)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the HNGE Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 68/100 (C+) score, HNGE faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($99.77) or 200D SMA ($68.16) invalidates the momentum regime and cuts Target Base ($120.68) toward Bear Floor ($94.13).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HNGE• $4.8M Crowd Pool • Kalshi / Polymarket Composite
Contract: “HNGE Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”
YES 68%NO 32%Trade / Inspect Odds →
INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your HNGE Position Size: $10,000

Shares at $115.48: 86.6 sh
$1,000$10,000$25,000$50,000$100,000
12M Bear Case FloorTarget $94.13
$8,151
$-1,849 (-18.5%)
12M Consensus BaseTarget $120.68
$10,450
+$450 (+4.5%)
12M Bull Case BreakoutTarget $142.40
$12,331
+$2,331 (+23.3%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100
● Strong Buy / Buy: 17● Hold: 9● Sell: 2
Wall Street FirmStance12M Target1Y AccuracyTrack Grade
Morgan StanleyInstitutional Equity DeskHOLD$12674%A
Goldman SachsSector Coverage LeadBUY$13469%B
JP MorganUS Large-Cap ResearchHOLD$10758%C
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (HNGE Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
HNGE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +136.20%⚡ TESTING RESISTANCE
2026-11-03O $116.9H $116.9L $114.3C $115.5VOL 2.89M
RES: $119.5SMA50: $99.77SMA200: $68.16
$122.8$101.0$79.18$57.36$35.54RES $119.5$115.52026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HNGE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HNGE Butterfly Map → + Track HNGE →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
22.3%/yr Implied 5Y Growth

vs. +50.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on HNGE today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HNGE. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HNGE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HNGE)

Technology Rank #105 of 715 ⚔️ QNT vs HNGE Full Matrix →

1. Head-to-Head Technology Peer Comparison (HNGE vs. QNT, AUR, JKHY, EPAM)

Industry: EDP Services (163 Tracked Issuers)

Across 715 tracked Technology securities in the Roarable RQD universe, Hinge Health Inc. (HNGE) ranks #105 by composite RQD confidence (68/100, grade C+) and #153 by equity capitalization ($9.22B). Within this direct 5-issuer industry benchmark cohort, EPAM leads on earnings valuation at 18.4x trailing P/E, while QNT leads on capital efficiency and profitability with 58.3% ROIC and — gross margin. EPAM currently holds the highest overall quantitative score in the immediate peer group at 83/100 (A-) compared with HNGE at 68/100 (C+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
HNGE ACTIVE
Hinge Health Inc.
C+ 68/100 — 79.6% -35.0% +1.01% $9.22B Benchmark Subject
QNT
Quantinuum Inc.
D+ 53/100 21.7x — 58.3% -7.89% $8.93B /qnt-vs-hnge →
AUR
Aurora Innovation Inc.
D- 37/100 — -30.0% -35.0% -2.98% $8.81B /aur-vs-hnge →
JKHY
Jack Henry & Associates Inc.
A- 82/100 24.6x 42.7% 20.5% +1.29% $11.31B /jkhy-vs-hnge →
EPAM
EPAM Systems Inc.
A- 83/100 18.4x 28.8% 17.1% +2.34% $7.25B /epam-vs-hnge →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001673743 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Hinge Health Inc. (HNGE) reported GAAP revenue of $587.9M (+50.6% vs. FY2024 revenue of $390.4M , and +100.8% cumulative change since FY2023) , GAAP net income of -$528.3M, operating cash flow of $171.4M, and free cash flow of $170.7M (+256.0% YoY). On the balance sheet, HNGE closed FY2025 with $744.8M in total assets against $164.8M in total debt (Altman Z-Score: 12.12, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $587.9M -$528.3M $171.4M $170.7M $744.8M $164.8M
FY2024 (FY) 2024-12-31 $390.4M -$11.9M $49.0M $48.0M $673.3M $115.5M
FY2023 (FY) 2023-12-31 $292.7M -$108.1M -$63.9M -$77.1M $5.19B $1.21B

3. HNGE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HNGE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Hinge Health Inc. (NYSE: HNGE) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 68/100 at a spot price of $115.48 (+1.01% 1D, market cap $9.22B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 19/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 10/20. Across 715 tracked Technology issuers, HNGE ranks #105 in composite RQD confidence.

How does HNGE compare to QNT and AUR in the Technology sector?

Within the Technology sector (EDP Services), HNGE carries a Roarable C+ (68/100 RQD), trailing P/E of N/A, gross margin of 79.6%, and ROIC of -35.0%. By comparison, QNT (Quantinuum Inc.) holds a D+ grade (53/100 RQD, P/E 21.7x, ROIC 58.3%, cap $8.93B) and AUR (Aurora Innovation Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $8.81B). Among the 5-stock peer group, EPAM leads on earnings multiple (18.4x) while QNT leads on capital efficiency (58.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HNGE?

Per HNGE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001673743), Hinge Health Inc. generated $587.9M in revenue (+50.6% YoY), -$528.3M in net income, and $170.7M in free cash flow against $744.8M in total assets and $164.8M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HNGE trading relative to its 50-day, 200-day, and 52-week technical levels?

HNGE last traded at $115.48 (+1.01% on volume of 2,314,382 shares), positioning the stock +15.75% above its 50-day simple moving average ($99.77) and +69.42% above its 200-day simple moving average ($68.16). Across its 52-week range of $30.08 to $117.55, HNGE sits at the 97.6% percentile with a 14-day RSI of 63.7 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.2% ($106.01 to $124.95).

Direct Sub-Reports: HNGE RQD Cockpit HNGE 12M Forecast HNGE Earnings & Move HNGE Dividends & DRIP HNGE Insiders & 13F HNGE Whale Options HNGE Profit Sankey HNGE News & Why
ROARABLE RATING BRIEF • RQD 68/100 (C+) ✓ SEC XBRL & RQD VERIFIED

HNGE — Hinge Health Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Hinge Health Inc. (HNGE) earns a live Roarable RQD composite score of 68/100, corresponding to a C+ letter grade (Roarable Hold) at a spot price of $115.48 (+1.01% 1D, market capitalization $9.22B).

  • Fundamental Cash Engine (13/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 79.6%, operating margin of -60.0%, and free cash flow yield of 1.81%.
  • Whale 13F & Options Flow (19/20) + Insider Conviction (10/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (10/20) + Forensic Balance Sheet (16/20): Incorporates a 1.24x equity beta, Altman Z-Score of 12.12, Piotroski F-Score of 7/9, and Debt/Equity of 0.86x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Hinge Health Inc. Is a NYSE-listed issuer classified in the Technology sector and the EDP Services industry. Gross margin of 79.6% is reported in the market data section.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Hinge Health Inc. (HNGE) reported $587.9M in annual revenue (up from $390.4M in FY2024, +50.6% YoY) and -$528.3M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($292.7M revenue, -$108.1M net income) through FY2025, HNGE scaled operating cash flow to $171.4M and free cash flow to $170.7M, backed by $744.8M in total assets against $164.8M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (C+ • RQD 68/100): Big institutional funds and options desks are actively positioning on the bullish side. Clean SEC annual filing review with no major hidden accounting time-bombs. With Fundamental Cash Engine at 13/20 and Institutional Whale Flow at 19/20, sustained execution supports upside toward the upper end of the $30.08 – $117.55 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.24x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The source data therefore does not identify upstream suppliers, downstream customers, or sector correlations. Second-order ripples cannot be mapped from the provided data. A prospective investor should note that the absence of linkage data is itself a gap, not evidence of independence.

  • Key Question #1: Can HNGE sustain or expand its -60.0% operating margin and -35.0% ROIC against EDP Services peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $587.9M and free cash flow of $170.7M, how will capital allocation balance growth reinvestment against $164.8M in total debt?
  • Key Question #3: How sensitive is HNGE's 29.0x forward P/E multiple to Technology capital spending cycles and macro interest-rate shifts (Beta 1.24x)?

HNGE Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Hinge Health Inc. (HNGE) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to HNGE Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HNGE Bull vs. Bear Conversation Board — What's Your Call at $115.48?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HNGE 🐻 33% BEARISH CONVICTION
1. Pick Your Side on HNGE:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
BR BreakoutHunter RQD DEBATE OPENER • Swing & Catalyst Trader 🐂 BULLISH 🎯 Target: $132.61 (+16.0%)
📌 Pinned Debate

Institutional accumulation and options positioning score 19/20 in the Roarable RQD rating, the strongest pillar, alongside a 12.12 Altm

Picked up a starter position in HNGE in my $100K Virtual Cash book at $114.32. Institutional accumulation and options positioning score 19/20 in the Roarable RQD rating, the strongest pillar, alongside a 12.12 Altman Z-Score.. Trading inside a $30.08–$117.55 52-week range with 1.81% FCF yield gives solid downside support if EDP Services multiples expand this quarter.

CapAlloc_Nerd 🐂 BULL

@BreakoutHunter Agree on the RQD 68/100 quality, though with 1.24 beta I'm scaling in with half-size at $114.32 and keeping dry powder in case we test $106.32.

ME MeanReversion_88 RQD DEBATE OPENER • Quantitative Statistical Arb 🐻 BEARISH 🎯 Target: $85.74 (-25.0%)
Spot @ $114.32

ROIC of -35%, operating margin of -60%, and a forward P/E of 29 leave the cash engine (13/20) and valuation exposed if earnings do not

Here is the bear case nobody on the bull side wants to address on HNGE: ROIC of -35%, operating margin of -60%, and a forward P/E of 29 leave the cash engine (13/20) and valuation exposed if earnings do not improve.. At 29.0x forward P/E, even a small guidance miss in EDP Services triggers a 12-15% air pocket.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%